{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T04:19:57Z","timestamp":1784002797971,"version":"3.55.0"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,7,3]],"date-time":"2027-07-03T00:00:00Z","timestamp":1814572800000},"content-version":"am","delay-in-days":701,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.bioorg.2025.108708","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T02:12:06Z","timestamp":1751422326000},"page":"108708","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Revisiting multi-pathway modulation with theophylline derivatives: Targeting STAT3, NF-\u03baB, and apoptotic signaling in breast cancer"],"prefix":"10.1016","volume":"163","author":[{"given":"Ola S.","family":"Afifi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amira A.","family":"Abdellatef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba A.","family":"Abd El Razik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shams El-Dine A.","family":"Shams El-Dine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa A.","family":"El-Tombary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Elrewiny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Hayakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed F.","family":"El-Yazbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisham A.","family":"Nematalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perihan A.","family":"Elzahhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2024","key":"10.1016\/j.bioorg.2025.108708_bb0005","first-page":"12","article-title":"Cancer statistics","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bioorg.2025.108708_bb0010","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13045-022-01341-0","article-title":"Recent advances in therapeutic strategies for triple-negative breast cancer","volume":"15","author":"Li","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bioorg.2025.108708_bb0015","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.3389\/fphar.2019.01195","article-title":"Inhibition of stat3 signaling pathway by natural product pectolinarigenin attenuates breast cancer metastasis","volume":"10","author":"Li","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.108708_bb0020","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10082003","article-title":"LLL12B, a Novel Small-Molecule STAT3 Inhibitor, Induces Apoptosis and Suppresses Cell Migration and Tumor Growth in Triple-Negative Breast Cancer Cells","author":"Pan","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.bioorg.2025.108708_bb0025","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.mce.2013.03.010","article-title":"Distinct roles of STAT3 and STAT5 in the pathogenesis and targeted therapy of breast cancer","volume":"382","author":"Walker","year":"2014","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bioorg.2025.108708_bb0030","doi-asserted-by":"crossref","first-page":"e1293","DOI":"10.1038\/cddis.2014.250","article-title":"Identification of a natural product-like STAT3 dimerization inhibitor by structure-based virtual screening","volume":"5","author":"Liu","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bioorg.2025.108708_bb0035","first-page":"257","article-title":"Myeloid STAT3 promotes lung tumorigenesis by transforming tumor immunosurveillance into tumor-promoting inflammation, Cancer","volume":"5","author":"Zhou","year":"2017","journal-title":"Immunol. Res."},{"key":"10.1016\/j.bioorg.2025.108708_bb0040","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s13046-019-1206-z","article-title":"STAT3 as a potential therapeutic target in triple negative breast cancer: a systematic review","volume":"38","author":"Qin","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bioorg.2025.108708_bb0045","doi-asserted-by":"crossref","first-page":"e1701","DOI":"10.1038\/cddis.2015.63","article-title":"Nifuroxazide induces apoptosis and impairs pulmonary metastasis in breast cancer model","volume":"6","author":"Yang","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bioorg.2025.108708_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/08977194.2018.1473393","article-title":"STAT3: a multifaceted oncoprotein","volume":"36","author":"Guanizo","year":"2018","journal-title":"Growth Factors"},{"key":"10.1016\/j.bioorg.2025.108708_bb0055","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1002\/pro.3519","article-title":"The molecular details of cytokine signaling via the JAK\/STAT pathway","volume":"27","author":"Morris","year":"2018","journal-title":"Protein Sci."},{"key":"10.1016\/j.bioorg.2025.108708_bb0060","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1084\/jem.185.6.1035","article-title":"Signal transducer and activator of transcription-3 (STAT3) is constitutively activated in normal, self-renewing B-1 cells but only inducibly expressed in conventional B lymphocytes","volume":"185","author":"Karras","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bioorg.2025.108708_bb0065","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.canlet.2017.12.003","article-title":"The role of STAT3 in leading the crosstalk between human cancers and the immune system","volume":"415","author":"Wang","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bioorg.2025.108708_bb0070","doi-asserted-by":"crossref","first-page":"755","DOI":"10.3390\/cancers17050755","article-title":"Targeting STAT3 for Cancer therapy: focusing on Y705, S727, or dual inhibition?","volume":"17","author":"Berkley","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bioorg.2025.108708_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117332","article-title":"Structural optimization and characterization of highly potent and selective STAT3 inhibitors for the treatment of triple negative breast cancer","volume":"287","author":"Jin","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108708_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21093070","article-title":"Can NF-\u03baB Be considered a valid drug target in neoplastic diseases? our point of view","author":"Labbozzetta","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.bioorg.2025.108708_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111737","article-title":"Synthetic E-guggulsterone derivative GSD-1 inhibits NF-\u03baB signaling and suppresses the metastatic potential of breast cancer cells","volume":"140","author":"Abdellatef","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bioorg.2025.108708_bb0090","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1158\/1535-7163.MCT-13-0464","article-title":"TPCA-1 is a direct dual inhibitor of STAT3 and NF-\u03baB and regresses mutant EGFR-associated human non-small cell lung cancers","volume":"13","author":"Nan","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bioorg.2025.108708_bb0095","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1089\/omi.2017.0020","article-title":"NF-\u03baB is a potential molecular drug target in triple-negative breast cancers","volume":"21","author":"Poma","year":"2017","journal-title":"OMICS"},{"key":"10.1016\/j.bioorg.2025.108708_bb0100","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2174\/0929867321666141106124315","article-title":"Targeting the NF\u03baB signaling pathways for breast cancer prevention and therapy","volume":"22","author":"Wang","year":"2015","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108708_bb0105","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.bioorg.2025.108708_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116371","article-title":"Design, synthesis, and biological evaluation of potent 1,2,3,4-tetrahydroisoquinoline derivatives as anticancer agents targeting NF-\u03baB signaling pathway","volume":"46","author":"Sim","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108708_bb0115","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.canlet.2017.03.016","article-title":"An anti-prostate cancer benzofuran-conjugated iridium(III) complex as a dual inhibitor of STAT3 and NF-\u03baB","volume":"396","author":"Kang","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bioorg.2025.108708_bb0120","article-title":"Lysine methyltransferase SMYD2 promotes triple negative breast cancer progression","volume":"9","author":"Li","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bioorg.2025.108708_bb0125","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.3389\/fphar.2018.01285","article-title":"Kinome-wide siRNA screening identifies Src-enhanced resistance of chemotherapeutic drugs in triple-negative breast Cancer cells","volume":"9","author":"Tzeng","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.108708_bb0130","doi-asserted-by":"crossref","first-page":"647","DOI":"10.7150\/thno.16827","article-title":"STAT3\/NF-\u03baB-regulated lentiviral TK\/GCV suicide gene therapy for cisplatin-resistant triple-negative breast Cancer","volume":"7","author":"Kuo","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.bioorg.2025.108708_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104569","article-title":"Design, synthesis and in silico insights of new 7,8-disubstituted-1,3-dimethyl-1H-purine-2,6(3H,7H)-dione derivatives with potent anticancer and multi-kinase inhibitory activities","volume":"107","author":"Mohamed","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108708_bb0140","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejmech.2019.05.015","article-title":"Synthesis and biological evaluation of novel xanthine derivatives as potential apoptotic antitumor agents","volume":"176","author":"Hisham","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108708_bb0145","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.753676","article-title":"Discovery of a series of theophylline derivatives containing 1,2,3-triazole for treatment of non-small cell lung Cancer","volume":"12","author":"Ye","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.108708_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.102997","article-title":"EGFR inhibitors and apoptotic inducers: design, synthesis, anticancer activity and docking studies of novel xanthine derivatives carrying chalcone moiety as hybrid molecules","volume":"89","author":"Abou-Zied","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108708_bb0155","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ejmech.2019.06.017","article-title":"Design, synthesis and activity of novel 2,6-disubstituted purine derivatives, potential small molecule inhibitors of signal transducer and activator of transcription 3","volume":"179","author":"Wang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108708_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111663","article-title":"Activity of 2,6,9-trisubstituted purines as potent PDGFR\u03b1 kinase inhibitors with antileukaemic activity","volume":"182","author":"\u0158ezn\u00ed\u010dkov\u00e1","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108708_bb0165","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1002\/jhet.3987","article-title":"Synthesis, anticancer, and computational studies of 1, 3, 4-oxadiazole-purine derivatives","volume":"57","author":"Shahzadi","year":"2020","journal-title":"J. Heterocyclic Chem."},{"key":"10.1016\/j.bioorg.2025.108708_bb0170","doi-asserted-by":"crossref","first-page":"11943","DOI":"10.1021\/acsomega.1c00424","article-title":"Synthesis, Hemolytic studies, and in silico Modeling of novel Acefylline-1,2,4-triazole hybrids as potential anti-cancer agents against MCF-7 and A549","volume":"6","author":"Shahzadi","year":"2021","journal-title":"ACS Omega"},{"key":"10.1016\/j.bioorg.2025.108708_bb0175","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1080\/01635581.2013.877497","volume":"66","author":"Sugimoto","year":"2014","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.bioorg.2025.108708_bb0180","first-page":"1449","article-title":"Purines and triazolo[4,3-e]purines containing pyrazole moiety as potential anticancer and antioxidant agents, future","volume":"10","author":"Shaaban","year":"2018","journal-title":"Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108708_bb0185","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.bioorg.2019.03.076","article-title":"Synthesis and biological evaluation of purine-pyrazole hybrids incorporating thiazole, thiazolidinone or rhodanine moiety as 15-LOX inhibitors endowed with anticancer and antioxidant potential","volume":"87","author":"Afifi","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108708_bb0190","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1021\/ml100224d","article-title":"Identification of purine-scaffold small-molecule inhibitors of stat3 activation by QSAR studies","volume":"2","author":"Shahani","year":"2011","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.108708_bb0195","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.2174\/0929867327999200820173853","article-title":"The emerging role of COX-2, 15-LOX and PPAR\u03b3 in metabolic diseases and Cancer: an introduction to novel multi-target directed ligands (MTDLs)","volume":"28","author":"Alaaeddine","year":"2021","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108708_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112439","article-title":"Expanding the anticancer potential of 1,2,3-triazoles via simultaneously targeting Cyclooxygenase-2, 15-lipoxygenase and tumor-associated carbonic anhydrases","volume":"200","author":"Elzahhar","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108708_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106874","article-title":"New 2-alkoxycyanopyridine derivatives as inhibitors of EGFR, HER2, and DHFR: synthesis, anticancer evaluation, and molecular modeling studies","volume":"141","author":"Hawas","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108708_bb0210","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.3390\/molecules27061814","article-title":"New 1,3,4-Thiadiazole derivatives with anticancer activity","volume":"27","author":"Janowska","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.108708_bb0215","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.2174\/1871520616666160628100936","article-title":"1,3,4-Thiadiazole based anticancer agents","volume":"16","author":"Aliabadi","year":"2016","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108708_bb0225","first-page":"1731","article-title":"Identification of some novel xanthine-based derivatives with bronchodilator activity, future","volume":"9","author":"Mohamed","year":"2017","journal-title":"Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108708_bb0230","first-page":"179","article-title":"Synthesis and properties of 8-Nitro-7-alkylated theophylline derivatives","volume":"41","author":"Mosselhi","year":"1993","journal-title":"Bull. Pol. Acad. Sci. Chem."},{"key":"10.1016\/j.bioorg.2025.108708_bb0235","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3998\/ark.5550190.0010.e05","article-title":"Synthesis, structure and antimicrobial evaluation of new derivatives of theophylline sugar hydrazones","volume":"2009","author":"Mosselhi","year":"2009","journal-title":"Arkivoc"},{"key":"10.1016\/j.bioorg.2025.108708_bb0240","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1007\/BF00813814","article-title":"[f]-fused purine-2,6-diones: synthesis of new [1,3,5]- and [1,3,6]-thiadiazepino-[3,2-f]-purine ring systems","volume":"125","author":"Hesek","year":"1994","journal-title":"Monatshefte F\u00fcr Chemie Chemical Monthly"},{"key":"10.1016\/j.bioorg.2025.108708_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116138","article-title":"Chromone-based small molecules for multistep shutdown of arachidonate pathway: simultaneous inhibition of COX-2, 15-LOX and mPGES-1 enzymes","volume":"266","author":"Elzahhar","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108708_bb0250","first-page":"996","article-title":"Synthesis and isomerism of hydrazones of 2-(5-thioxo-4,5-dihydro-1,3,4-thiadiazol-2-ylthio)acetohydrazide","volume":"5","author":"Kuodis","year":"2007","journal-title":"Cent. Eur. J. Chem."},{"key":"10.1016\/j.bioorg.2025.108708_bb0255","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/j.bmcl.2009.02.116","article-title":"Synthesis and antiviral activities of novel acylhydrazone derivatives targeting HIV-1 capsid protein","volume":"19","author":"Tian","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.108708_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.139228","article-title":"Synthesis, characterization, and MAO inhibitory activities of three new drug-like N-acylhydrazone derivatives","volume":"1318","author":"Ta\u015fci","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2025.108708_bb0265","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1242\/jcs.057109","article-title":"Stat3 promotes directional cell migration by regulating Rac1 activity via its activator \u03b2PIX","volume":"122","author":"Teng","year":"2009","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bioorg.2025.108708_bb0270","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/cr.2008.18","article-title":"STAT3 as a target for inducing apoptosis in solid and hematological tumors","volume":"18","author":"Siddiquee","year":"2008","journal-title":"Cell Res."},{"key":"10.1016\/j.bioorg.2025.108708_bb0275","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1021\/acs.jmedchem.2c01408","article-title":"Inclusion of nitrofurantoin into the realm of Cancer chemotherapy via biology-oriented synthesis and drug repurposing","volume":"66","author":"Elzahhar","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108708_bb0280","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.lfs.2016.08.009","article-title":"Solid Ehrlich carcinoma reproduces functional and biological characteristics of cancer cachexia","volume":"162","author":"Frajacomo","year":"2016","journal-title":"Life Sci."},{"key":"10.1016\/j.bioorg.2025.108708_bb0285","first-page":"22","article-title":"Features and applications of Ehrlich tumor model in cancer studies: a literature review, translational","volume":"4","author":"Radulski","year":"2023","journal-title":"Breast Cancer Res."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108708_bb0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-14776-0","article-title":"Novel Benzylidene Thiazolidinedione Derivatives as Partial PPAR\u03b3 Agonists and their Antidiabetic Effects on Type 2 Diabetes","volume":"7","author":"Yasmin","year":"2017","journal-title":"Scientific Reports"},{"key":"10.1016\/j.bioorg.2025.108708_bb0295","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/jmr.1047","article-title":"Characterization of molecular recognition of STAT3 SH2 domain inhibitors through molecular simulation","volume":"24","author":"Park","year":"2011","journal-title":"J. Mol. Recognit."},{"key":"10.1016\/j.bioorg.2025.108708_bb0300","doi-asserted-by":"crossref","first-page":"988","DOI":"10.6026\/97320630008988","article-title":"Molecular docking studies on inhibition of Stat3 dimerization by curcumin natural derivatives and its conjugates with amino acids","volume":"8","author":"Kumar","year":"2012","journal-title":"Bioinformation"},{"key":"10.1016\/j.bioorg.2025.108708_bb0305","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.3389\/fphar.2022.836724","article-title":"Novel STAT3 inhibitors targeting STAT3 dimerization by binding to the STAT3 SH2 domain","volume":"13","author":"Hua","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.108708_bb0310","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1463-1326.2011.01402.x","article-title":"JSH-23 targets nuclear factor-kappa B and reverses various deficits in experimental diabetic neuropathy: effect on neuroinflammation and antioxidant defence","volume":"13","author":"Kumar","year":"2011","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.bioorg.2025.108708_bb0315","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.intimp.2011.12.009","article-title":"Inhibition of the NF-\u03baB signaling pathway by the curcumin analog, 3,5-bis(2-pyridinylmethylidene)-4-piperidone (EF31): anti-inflammatory and anti-cancer properties","volume":"12","author":"Olivera","year":"2012","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bioorg.2025.108708_bb0320","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.3892\/ijo.2014.2624","article-title":"Identification of Hirsutine as an anti-metastatic phytochemical by targeting NF-\u03baB activation","volume":"45","author":"Lou","year":"2014","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bioorg.2025.108708_bb0325","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1248\/bpb.b20-00571","article-title":"Anti-metastatic effects of baicalein by targeting STAT3 activity in breast Cancer cells","volume":"43","author":"Susmitha","year":"2020","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.bioorg.2025.108708_bb0330","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/cas.12685","article-title":"Mammary tissue microenvironment determines T cell-dependent breast cancer-associated inflammation","volume":"106","author":"Takahashi","year":"2015","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bioorg.2025.108708_bb0335","doi-asserted-by":"crossref","first-page":"6618","DOI":"10.1038\/s41598-021-85675-8","article-title":"Erianthridin suppresses non-small-cell lung cancer cell metastasis through inhibition of Akt\/mTOR\/p70S6K signaling pathway","volume":"11","author":"Pothongsrisit","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2025.108708_bb0340","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.bioorg.2017.10.016","article-title":"Azole-hydrazone derivatives: design, synthesis, in vitro biological evaluation, dual EGFR\/HER2 inhibitory activity, cell cycle analysis and molecular docking study as anticancer agents","volume":"76","author":"Labib","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108708_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105035","article-title":"Transforming iodoquinol into broad spectrum anti-tumor leads: repurposing to modulate redox homeostasis","volume":"113","author":"Chaaban","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108708_bb0350","series-title":"Guide for the Care and Use of Laboratory Animals","author":"Guide for the Care and Use of Laboratory Animals","year":"2011"},{"key":"10.1016\/j.bioorg.2025.108708_bb0355","first-page":"271","article-title":"Long-term in vitro cultivation of some mouse ascites Tumors: Ehrlich ascites carcinoma","volume":"26","author":"Cailleau","year":"1961","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"10.1016\/j.bioorg.2025.108708_bb0360","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.btre.2015.04.004","article-title":"Validation of three viable-cell counting methods: Manual, semi-automated, and automated","volume":"7","author":"Cadena-Herrera","year":"2015","journal-title":"Biotechnol Rep (Amst)"},{"key":"10.1016\/j.bioorg.2025.108708_bb0365","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/BF00300234","article-title":"Determination of subcutaneous tumor size in athymic (nude) mice","volume":"24","author":"Tomayko","year":"1989","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.108708_bb0370","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/jso.2930310402","article-title":"Tumor measurement in the nude mouse","volume":"31","author":"Euhus","year":"1986","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.bioorg.2025.108708_bib375","doi-asserted-by":"crossref","first-page":"115333","DOI":"10.1016\/j.ejmech.2023.115333","article-title":"Modulating leishmanial pteridine metabolism machinery via some new coumarin-1,2,3-triazoles: Design, synthesis and computational studies","volume":"253","author":"Hassan","year":"2023","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bioorg.2025.108708_bib376","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1080\/14756366.2021.1887169","article-title":"Challenging inflammatory process at molecular, cellular and in vivo levels via some new pyrazolyl thiazolones","volume":"36","author":"Elzahhar","year":"2021","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.bioorg.2025.108708_bib377","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13065-023-00944-z","article-title":"Insights on the in-vitro binding interaction between donepezil and bovine serum albumin","volume":"17","author":"El Gammal","year":"2023","journal-title":"BMC Chem"},{"key":"10.1016\/j.bioorg.2025.108708_bib378","doi-asserted-by":"crossref","first-page":"117415","DOI":"10.1016\/j.ejmech.2025.117415","article-title":"Novel thiazolones for the simultaneous modulation of PPAR\u03b3, COX-2 and 15-LOX to address metabolic disease-associated portal inflammation","volume":"289","author":"El-Shoukrofy","year":"2025","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bioorg.2025.108708_bib379","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1021\/acsptsci.5c00011","article-title":"Multi-Target Glitazones for Modulating Peroxisome Proliferator-Activated Receptor-\u03b3, Cyclooxygenase-2, and Carbonic Anhydrases for the Management of Metabolic Dysfunction","volume":"8","author":"Elzahhar","year":"2025","journal-title":"ACS Pharmacol Transl Sci"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825005887?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825005887?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T05:02:02Z","timestamp":1776920522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825005887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":78,"alternative-id":["S0045206825005887"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108708","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Revisiting multi-pathway modulation with theophylline derivatives: Targeting STAT3, NF-\u03baB, and apoptotic signaling in breast cancer","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108708","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108708"}}